Cleveland Clinic physician tells patients to skip BPC-157 for now
Lifestyle and obesity specialist Layth Tumah says nearly all BPC-157 evidence is preclinical and no human safety data exist.
PR
By Priya Raman · Science Reporter
Oct 13 00:11 ETSource: Cleveland Clinic Health Essentials
The wire
- 01Cleveland Clinic published guidance stating BPC-157 is an unapproved experimental peptide stuck in early research, with most data preclinical and no established human safety or efficacy.
- 02Patients increasingly ask clinicians about the compound after influencer claims on healing and brain health; the article notes it is only sold online as research-use-only gray-market material.
- 03Tumah says the peptide may promote angiogenesis in early studies but that approval for any condition remains years away.
From the source
Read at health.clevelandclinic.orgWhat You Need To Know About BPC-157
This experimental peptide isn’t approved to treat or prevent any health condition
